Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes

Clinical and Experimental Immunology

Volumn 124, Issue 2, 2001, Pages 214-222

  Amakata, Y ^a   Fujiyama, Y ^a   Andoh, A ^a   Hodohara, K ^a   Bamba, T ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Costimulation; IFN ; IL 12

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 39; INTERLEUKIN 12;

ARTICLE; CELL ACTIVATION; CELL CONTACT; CELL INTERACTION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL;

ANTIGENS, CD56; COCULTURE TECHNIQUES; DENDRITIC CELLS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; MONOCYTES; RECEPTORS, IGG; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0034951434     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01550.x     Document Type: Article

References (45)

1. + hematopoietic progenitor cells
2. Differentiation of human dendritic cells from monocytes in vitro
3. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating facter plus interleukin 4 and down regulated by tumor necrosis factor α
4. On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo
5. The dendritic cell system and its role in immunogenicity
6. Distinct features of dendritic cells and anti-Ig activated B cells as stimurators of the primary mixed leukocyte reaction
7. Role of tumor necrosis factor-alpha in dendritic cell-mediated primary mixed leucocyte reactions
8. Dendritic cells pulsed protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ
9. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro
10. A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1) - Pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen
11. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34 (+) hematopoietic progenitor cells
12. Dendritic cell-based immunotherapy of prostate cancer: Immune monitoring of a phase II clinical trial
13. Dendritic cells and the control of immunity
14. Natural killer cells: Endotherial interaction, migration, and target cell recognition
15. Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues
16. Immunotherapy of liver metastasis of human gastric carcinoma with interleukin-2-activated natural killer cells
17. Expression and regulation of chemikine receptors in human natural killer cells
18. Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication
19. + helper cells
20. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction
21. CD28/B7 system of T cell costimulation
22. bright natural killer subsets: Characterization of distinct functional response to interleukin-2 and the c-kit ligand
23. bright human NK cell subset is the most potent NK producer of macropharge activating factors
24. Later development of Fas ligand-mediated cytotoxicity as compared with granule mediated cytotoxicity during the maturation of natural killer cells
25. Cord blood CD16+CD56- cells with low lytic activity are possible precursors of mature natural killer cells
26. Identification and purification of natural killer sell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
27. Cloning of cDNA for natural killer cell sell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells
28. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor)
29. Dendritic cells produce IL-12 and direct the development of Th1 cells from native CD4+T cells
30. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 IL-10
31. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
32. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation
33. Involvement of CD28 in MHC-unrestriced cytotoxicity mediated by a human natural killer leukemia cell line
34. CD28-mediated costimuration is necessary for optimal proliferation of murine NK cells
35. Triggering of natural killer cells by the costimulatory molecule, CD80 (B7-1)
36. IL-18 andCD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-γ
37. A new mechanism of NK cell cytotoxicity activation: The CD40-CD40 ligand interaction
38. Triggering of murine NK cells by CD40 and CD86 (B7-2)
39. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo
40. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity
41. Indomethacin inhibits kidney metastasis in bomirski melanoma-bearing hamsters, and modulates natural killer cytotoxic activity of tumor hosts in vivo and in vitro
42. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats
43. Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease
44. Role of natural killer cells in cancer